Loading organizations...
§ Venture Capital · Paris, France
European business angel network facilitating seed investments for early-stage healthcare startups in biotech, medtech, and digital health.
Based in Paris, France, Angels Santé is a business angel network that connects private investors with early-stage healthcare startups to provide seed capital and strategic industry expertise. The organization focuses exclusively on the biotechnology, medtech, digital health, diagnostics, and animal health sectors, typically participating in early funding rounds ranging from €200,000 to €2 million. Operating with an estimated staff of 51 to 100 employees, the network generates approximately $4 million in annual revenue and holds an estimated valuation of $19.8 million. The group comprises over 200 active individual investors and collaborates with major institutional partners such as EIT Health, Bpifrance, and France Angels to facilitate cross-border European syndication. Its active investment portfolio includes notable emerging European healthcare technology companies like Implicity and Diabeloop. Angels Santé was established as a non-profit association in 2008 by undisclosed founders.
Key people at Angels Sante.
Angels Sante has 3 tracked investments across 3 companies. The latest tracked deal is $1.0M Seed in Leto in December 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 1, 2022 | Leto | $1.0M Seed | — | — |
| Feb 1, 2018 | Datananas | $1.0M Series U | — | — |
| Mar 1, 2014 | Fastory | $830K Seed | — | — |
Key people at Angels Sante.
Angels Santé is Europe’s largest angel investor network dedicated exclusively to healthcare and life sciences startups. Founded in 2008 and based in Paris, it focuses on identifying and funding early-stage European startups that offer economically responsible and medically impactful solutions to health system challenges. The firm provides seed capital, expertise, and access to a broad network of specialized and non-specialized investors to accelerate startup growth. Its investment philosophy centers on supporting innovative health projects that address current and future medico-economic issues, thereby fostering sustainable healthcare innovation across Europe[1][2][4].
Angels Santé was established in 2008 to fill a gap in healthcare investment by creating a dedicated angel network focused on health innovation. The founding partners brought extensive expertise in healthcare and investment, aiming to connect investors with promising startups in biotech, medtech, e-health, and related sectors. Over time, Angels Santé has evolved into a pan-European health investor network, facilitating cross-border fundraising and providing comprehensive support to startups through capital, mentorship, and syndication. Key figures include board members such as Bruno Génin, who contribute to its strategic direction[1][2].
Angels Santé rides the growing trend of specialized healthcare investment, responding to increasing demand for innovative solutions in aging populations, rising healthcare costs, and digital health transformation. The timing is critical as European health systems seek sustainable, technology-driven improvements. By mobilizing both specialized and non-specialized investors, Angels Santé helps bridge funding gaps for early-stage health startups, accelerating innovation diffusion and contributing to a more resilient healthcare ecosystem. Its cross-border approach also strengthens European health tech integration and competitiveness[1][2].
Looking ahead, Angels Santé is poised to deepen its influence by expanding its investor base and portfolio across emerging health technologies such as digital therapeutics, personalized medicine, and biotech innovations. Trends like AI in healthcare and telemedicine will likely shape its investment focus. The network’s ability to facilitate cross-border funding and provide operational support will remain a key advantage, potentially positioning it as a leading driver of European health innovation in the coming years. Its continued commitment to economically responsible and medically impactful projects will sustain its role as a critical enabler in the healthcare startup ecosystem[1][2][4].
